Salvage Second Hematopoietic Cell Transplantation in Myeloma

Autologous hematopoietic cell transplantation (AHCT) as initial therapy of patients with multiple myeloma (MM) improves survival. However, data to support this approach for relapsed/progressive disease after initial AHCT (AHCT1) are limited. Using Center for International Blood and Marrow Transplant...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Michaelis, Laura C., Saad, Ayman, Zhong, Xiaobo, Le-Rademacher, Jennifer, Freytes, Cesar O., Marks, David I., Lazarus, Hillard M., Bird, Jennifer M., Holmberg, Leona, Kamble, Rammurti T., Kumar, Shaji, Lill, Michael, Meehan, Kenneth R., Saber, Wael, Schriber, Jeffrey, Tay, Jason, Vogl, Dan T., Wirk, Baldeep, Savani, Bipin N., Gale, Robert P., Vesole, David H., Schiller, Gary J., Abidi, Muneer, Anderson, Kenneth C., Nishihori, Taiga, Kalaycio, Matt E., Vose, Julie M., Moreb, Jan S., Drobyski, William, Munker, Reinhold, Roy, Vivek, Ghobadi, Armin, Holland, H. Kent, Nath, Rajneesh, To, L. Bik, Maiolino, Angelo, Kassim, Adetola A., Giralt, Sergio A., Landau, Heather, Schouten, Harry C., Maziarz, Richard T., Mikhael, Joseph, Kindwall-Keller, Tamila, Stiff, Patrick J., Gibson, John, Lonial, Sagar, Krishnan, Amrita, Dispenzieri, Angela, Hari, Parameswaran
Formato: Artigo
Idioma:Inglês
Publicado: 2013
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3816739/
https://ncbi.nlm.nih.gov/pubmed/23298856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2013.01.004
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares